A detailed history of Brevan Howard Capital Management LP transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 15,682 shares of TERN stock, worth $91,896. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,682
Holding current value
$91,896
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.49 - $10.8 $101,776 - $169,365
15,682 New
15,682 $130,000
Q4 2023

Feb 14, 2024

BUY
$3.37 - $6.86 $36,537 - $74,376
10,842 New
10,842 $70,000

Others Institutions Holding TERN

About Terns Pharmaceuticals, Inc.


  • Ticker TERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,613,800
  • Market Cap $220M
  • Description
  • Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...
More about TERN
Track This Portfolio

Track Brevan Howard Capital Management LP Portfolio

Follow Brevan Howard Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brevan Howard Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Brevan Howard Capital Management LP with notifications on news.